Search

Insulet Corp

Fermé

SecteurSoins de santé

137.83 4.57

Résumé

Variation du prix de l'action

24h

Actuel

Min

131.56

Max

132.88

Chiffres clés

By Trading Economics

Revenu

3.9M

95M

Ventes

40M

802M

P/E

Moyenne du Secteur

27.618

56.597

BPA

1.66

Marge bénéficiaire

11.85

Employés

5,400

EBITDA

-22M

132M

Dividendes

By Acuity

Prochains Résultats

5 nov. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-1.5B

10B

Ouverture précédente

133.26

Clôture précédente

137.83

Sentiment de l'Actualité

By Acuity

64%

36%

287 / 339 Classement par Healthcare

Insulet Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

10 sept. 2026, 20:07 UTC

News

Insulet Corp is under investigation by Bronstein, Gewirtz & Grossman, LLC for potential corporate wrongdoing, contributing to a decline in shares during Thursday's session.

9 sept. 2026, 23:16 UTC

Insulet Corp shares are higher in after-market hours, gaining since Wednesday's close. This follows a recent trend of four consecutive lower finishes.

8 sept. 2026, 20:07 UTC

News
Social Media

Insulet Corp shares are lower amid an investigation by Bronstein, Gewirtz & Grossman, LLC, targeting potential claims of corporate wrongdoing.

4 sept. 2026, 20:07 UTC

Insulet Corp's shares are lower today, reaching a session low earlier. The stock remains above its 20-day moving average amid notable volatility.

3 sept. 2026, 22:46 UTC

Insulet Corp shares are lower in after-market hours, despite earlier gains. No specific news was identified to explain the price movement.

2 sept. 2026, 19:36 UTC

Insulet Corp shares are declining today, despite an earlier peak. Broader market concerns include heightened geopolitical tensions and potential supply disruptions.

1 sept. 2026, 23:36 UTC

Insulet Corp's shares are higher in after-market hours, following notable trading activity. The stock remains above its 20-day moving average despite negative market sentiment.

31 août 2026, 20:07 UTC

News

Insulet Corp reported 23.5% revenue growth for Q2 2026, though it lowered FY2026 guidance. Shares are gaining today amid broader market trends.

28 août 2026, 19:16 UTC

Insulet Corp's shares are higher today, reflecting positive market sentiment despite earlier intraday volatility. No specific news was identified to explain the movement.

27 août 2026, 19:26 UTC

News

Insulet Corp faces a class action lawsuit alleging securities fraud related to manufacturing defects, contributing to a decline in shares today.

26 août 2026, 19:16 UTC

Social Media

Insulet Corp shares are higher today, supported by over $226,000 in December $200 call options. Recent PCE data may also influence market sentiment.

25 août 2026, 23:16 UTC

News

Insulet Corp shares lower in after-market hours amid a class action lawsuit alleging false statements about manufacturing controls and safety compliance.

24 août 2026, 19:56 UTC

News

Insulet Corp shares are lower amid negative sentiment from two class action lawsuits alleging securities fraud related to product safety concerns.

21 août 2026, 19:56 UTC

Insulet Corp shares are higher today, reflecting positive market momentum. Broader market gains, particularly in cryptocurrency, contribute to the stock's upward movement.

20 août 2026, 23:11 UTC

Insulet Corp shares are trading lower in after-market hours, continuing a decline that follows a reversal from earlier highs. No specific news was identified.

19 août 2026, 23:01 UTC

Insulet Corp shares are higher in after-market trading, continuing a trend of gains over the last three sessions without any specific news driving the movement.

18 août 2026, 20:03 UTC

Insulet Corp's shares are higher today, having previously peaked before pulling back. The stock has advanced since Monday's close, despite no specific news.

17 août 2026, 20:06 UTC

News

Insulet Corp shares are lower amid a class action lawsuit alleging securities law violations related to safety risks in manufacturing processes.

14 août 2026, 20:06 UTC

News

Insulet Corp faces a securities fraud class action lawsuit from Levi & Korsinsky, LLP, contributing to a decline in shares during regular trading hours.

13 août 2026, 23:06 UTC

Insulet Corp shares are lower in after-market hours, with no specific news identified to explain the decline. The stock remains near the middle of its one-month range.

12 août 2026, 19:36 UTC

Insulet Corp shares are higher during Wednesday's session, recovering from earlier lows. Broader market inflation data may be supporting positive sentiment.

11 août 2026, 19:46 UTC

Insulet Corp's shares are higher, continuing a four-session trend, despite no specific news. Market participants are reacting to recent economic indicators and Fed rate expectations.

10 août 2026, 22:56 UTC

News

Insulet Corp shares are lower in after-market trading following a class action lawsuit from Pomerantz LLP alleging false statements about manufacturing practices and product safety.

7 août 2026, 19:36 UTC

News

Insulet Corp shares are higher as Deutsche Bank initiates coverage with a "buy" rating and a $190 price target, despite a downgrade from Oppenheimer.

6 août 2026, 23:32 UTC

News

Insulet Corp shares are lower in after-market hours following a downgrade to Market Perform by Leerink Partners and a reduced price target of $145.

5 août 2026, 23:46 UTC

Insulet Corp. shares traded lower in after-market hours, reflecting routine activity and cautious market sentiment amid disappointing private sector employment data.

4 août 2026, 23:56 UTC

Insulet Corp shares are lower in after-market hours, showing little change since Tuesday's close amid a lack of specific company news.

3 août 2026, 19:36 UTC

Correlated Moves

Insulet Corp's shares are higher today, supported by a positive trend in the medical devices sector. The stock remains above its 20-day moving average.

31 juil. 2026, 20:06 UTC

News

Insulet Corp shares are declining amid a securities class action lawsuit alleging misrepresentations about the safety of its Omnipod products.

29 juil. 2026, 18:43 UTC

Insulet Corp shares are higher, driven by gains in the Health Care Equipment sub-sector. The stock remains well above its 20-day moving average.

Comparaison

Variation de prix

Insulet Corp prévision

Note du Consensus

By TipRanks

Achat Modéré

20 ratings

11

Achat

9

Maintien

0

Vente

Sentiment

By Acuity

287 / 339Classement par Soins de santé

Sentiment de l'Actualité

Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
help-icon Live chat